155 related articles for article (PubMed ID: 34866939)
1. Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study.
Feng Q; Tang LJ; Luo DH; Wang Y; Wu N; Chen H; Chen MX; Jiang L; Jin R
Cancer Manag Res; 2021; 13():8809-8819. PubMed ID: 34866939
[TBL] [Abstract][Full Text] [Related]
2. Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients.
You J; Zhang H; Shen Y; Chen C; Liu W; Zheng M; Van Poucke S; Guo G; Huang Z
Onco Targets Ther; 2017; 10():2199-2208. PubMed ID: 28458563
[TBL] [Abstract][Full Text] [Related]
3. The effect of metabolic syndrome on postoperative complications and long-term survival of patients with colorectal cancer.
Zhu C; Mao C; Cai W; Zheng J; Yang H; You T; Chen J; Yu Y; Shen X; Li L
Front Oncol; 2023; 13():1036458. PubMed ID: 37434983
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome-related sarcopenia is associated with worse prognosis in patients with gastric cancer: A prospective study.
Xu LB; Zhang HH; Shi MM; Huang ZX; Zhang WT; Chen XD; Cai YQ; Zhu GB; Shen X; Chen WJ
Eur J Surg Oncol; 2020 Dec; 46(12):2262-2269. PubMed ID: 32800596
[TBL] [Abstract][Full Text] [Related]
5. Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study.
Ahmadi A; Noroozi M; Pourhoseingholi MA; Hashemi-Nazari SS
J Renal Inj Prev; 2015; 4(1):15-9. PubMed ID: 25848641
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Metabolic Syndrome on Colorectal Cancer Prognosis after Primary Surgery.
Tao W; Yuan C; Kang B; Liu XY; Cheng YX; Zhang B; Wei ZQ; Peng D
Nutr Cancer; 2023; 75(1):331-338. PubMed ID: 35976038
[TBL] [Abstract][Full Text] [Related]
7. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
8. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.
Chen DZ; Ji FY; Xu QM; Wu XX; Cai C; Zhang LJ; Li LJ
Sci Rep; 2018 Jan; 8(1):972. PubMed ID: 29343809
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract][Full Text] [Related]
11. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer.
Yang X; Li X; Dong Y; Fan Y; Cheng Y; Zhai L; Zhang S; Zhou J; Wang J
Front Endocrinol (Lausanne); 2021; 12():780769. PubMed ID: 34975754
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
13. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Chen G; Liang B; Zhang H; Ji K; Huang J; Lin J; Zheng X; Niu W
Int J Cancer; 2016 Dec; 139(12):2705-2713. PubMed ID: 27560834
[TBL] [Abstract][Full Text] [Related]
14. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
16. Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients.
Mafiana RN; Al-Kindi MS; Mafiana N; Al Lawati AS; Al Moundhri M
J Cancer Epidemiol; 2019; 2019():6527457. PubMed ID: 31139216
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia Is Associated With a Higher Prevalence of Metabolic Syndrome in Military Individuals.
Liu CW; Chang WC; Lee CC; Chen KH; Wu YW; Hwang JJ
Mil Med; 2018 Nov; 183(11-12):e391-e395. PubMed ID: 29750266
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia is a Adverse Prognostic Factor for Colon Cancer Patients.
Yan J; Zhu C
Int J Gen Med; 2021; 14():3001-3006. PubMed ID: 34234529
[TBL] [Abstract][Full Text] [Related]
19. Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome.
Porchia LM; Gonzalez-Mejia ME; Torres-Rasgado E; Ruiz-Vivanco G; Pérez-Fuentes R
Diabetes Metab Syndr; 2018 May; 12(3):325-331. PubMed ID: 29292186
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.
Nagahama K; Inoue T; Kohagura K; Ishihara A; Kinjo K; Ohya Y
Hypertens Res; 2014 Mar; 37(3):232-8. PubMed ID: 24173358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
